Neuroinflammation predicts disease progression in PSP
Researchers have been able to show that Progressive Supranuclear Palsy (PSP) is associated with brain inflammation in addition to tau protein.
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease that can cause problems with balance, movement, vision, speech and swallowing. It occurs when brain cells become damaged from the build-up of protein called tau.
Patients with PSP volunteered for a trial which would involve having their brains scanned with a PET (Positron Emission Tomography) scan. The patients were then followed up for a few years.
Researchers were able to map where the inflammation occurred in the brain and highlight any significant changes. It could mean that using PET scans may be able to help clinicians see how PSP is progressing in their patients.
